Literature DB >> 19384945

Mass screening for colorectal cancer is not justified in most developing countries.

René Lambert1, Catherine Sauvaget, Rengaswamy Sankaranarayanan.   

Abstract

Most developed countries insist on the prevention of colorectal cancer (CRC) and offer screening to the population. Mass screening is proposed to both sexes in the population aged 50 years or more. Colonoscopy is then offered to persons having a positive faecal occult blood test. This recommendation should not be diffused over the world without considering the distinct dimensions of the risk and resources in developed and developing countries. A national screening policy is legitimate in developed countries like Japan, South Korea, and in North America and Europe. On the other hand, a mass screening policy for CRC is not recommended in most developing countries. The limited amount of resources attributed to health care for cancer should concern other indications in the control of common cancers, particularly in the cervix or liver. Indeed the risk of CRC is very low in most regions of Africa, and in some countries of South America and Asia. Copyright 2009 UICC.

Entities:  

Mesh:

Year:  2009        PMID: 19384945     DOI: 10.1002/ijc.24371

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Important Role of Health Surveillance Systems in Community-Based Colorectal Cancer Screening.

Authors:  Ann Chao; Sudha Sivaram
Journal:  Oncologist       Date:  2018-07-26

2.  An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria.

Authors:  Gregory C Knapp; Avinash Sharma; Bolatito Olopade; Olusegun I Alatise; Olalekan Olasehinde; Olujide O Arije; Philip E Castle; T Peter Kingham
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

3.  Incidence and risk factors of synchronous colorectal cancer in patients with esophageal cancer: an analysis of 480 consecutive colonoscopies before surgery.

Authors:  Naoya Yoshida; Yuka Tamaoki; Yoshifumi Baba; Yasuo Sakamoto; Yuji Miyamoto; Masaaki Iwatsuki; Takashi Shono; Hideaki Miyamoto; Masanori Imuta; Junji Kurashige; Hiroshi Sawayama; Ryuma Tokunaga; Masayuki Watanabe; Yutaka Sasaki; Yasuyuki Yamashita; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2016-07-01       Impact factor: 3.402

4.  Estimating the incidence of colorectal cancer in South East Asia.

Authors:  Inka Kokki; Angeliki Papana; Harry Campbell; Evropi Theodoratou
Journal:  Croat Med J       Date:  2013-12       Impact factor: 1.351

5.  Tale of Two Fellows.

Authors:  Karin Purshouse; Twalib Ngoma; David Kerr
Journal:  J Glob Oncol       Date:  2017-08-21

6.  A Label-Free, Quantitative Fecal Hemoglobin Detection Platform for Colorectal Cancer Screening.

Authors:  Gita V Soraya; Thanh C Nguyen; Chathurika D Abeyrathne; Duc H Huynh; Jianxiong Chan; Phuong D Nguyen; Babak Nasr; Gursharan Chana; Patrick Kwan; Efstratios Skafidas
Journal:  Biosensors (Basel)       Date:  2017-05-05

7.  Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells.

Authors:  Hai-Ming Chen; Zheng-Quan Lai; Hui-Jun Liao; Jian-Hui Xie; Yan-Fang Xian; Yun-Long Chen; Siu-Po Ip; Zhi-Xiu Lin; Zi-Ren Su
Journal:  Int J Mol Med       Date:  2018-01-09       Impact factor: 4.101

8.  Estimating the incidence of colorectal cancer in Sub-Saharan Africa: A systematic analysis.

Authors:  Alice Graham; Davies Adeloye; Liz Grant; Evropi Theodoratou; Harry Campbell
Journal:  J Glob Health       Date:  2012-12       Impact factor: 4.413

9.  Faecal immunochemical test-based colorectal cancer screening in Mexico: an initial experience.

Authors:  José María Remes-Troche; Gabriela Hinojosa-Garza; Priscilla Espinosa-Tamez; Arturo Meixueiro-Daza; Peter Grube-Pagola; Katherine Van Loon; Michael B Potter; Martin Lajous
Journal:  Fam Pract       Date:  2020-07-23       Impact factor: 2.290

10.  Genetic ancestry is associated with colorectal adenomas and adenocarcinomas in Latino populations.

Authors:  Gustavo Hernandez-Suarez; Maria Carolina Sanabria; Marta Serrano; Oscar F Herran; Jesus Perez; Jose L Plata; Jovanny Zabaleta; Albert Tenesa
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.